Saluja et al. The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers. Frontiers in Oncology, 24 July 2018.
Murray et al. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival. Journal of Cancer Research and Clinical Oncology, 10 July 2018.
Symonds et al. Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection. Clinical Epigenetics, 16 May 2018.
Jedi et al. Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues. Clinical Medicine Insights: Oncology, 10 May 2018.
Shapiro et al. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol advance online publication, 10 October 2017; doi: 10.1038/ajg.2017.285
Murray et al. Validation of a Circulating Tumor-Derived DNA Blood Test for Detection of Methylated BCAT1 and IKZF1 DNA. JALM 2017, doi: 10.1373/jalm.2017.023135
Mitchell et al. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer. Genes 2016, 7(12), 125; doi:10.3390/genes7120125
Young et al. A Cross-sectional Study Comparing a Blood Test for Methylated BCAT1 and IKZF1 Tumor-derived DNA with CEA for Detection of Recurrent Colorectal Cancer. Cancer Medicine. doi:10.1002/cam4.868
Symonds et al. A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clin Trans Gastro. 2016; 7, e137.
Pedersen et al. A Two-Gene Blood Test for Methylated DNA Sensitive for Colorectal Cancer. PLoS One 2015;10(4):e0125041.
Symonds et al. Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Fecal then Blood Based Non-Invasive Tests. Asian Pac J Cancer Prev, 16 (18), 8455-8460.
Pedersen et al. Evaluation of an Assay for Methylated BCAT1 and IKZF1 in Plasma for Detection of Colorectal Neoplasia. BMC CANCER 15(1):654. October 2015.
Mitchell et al. A Panel of Genes Methylated with High Frequency in Colorectal Cancer. BMC Cancer. 2014;14:54.
Pedersen et al. CAHM, a Long Non-Coding RNA Gene Hypermethylated in Colorectal Neoplasia.Epigenetics. 2014 Aug;9(8):1071-82.
Collins et al. Screening for Colorectal Cancer and Advanced Colorectal Neoplasia in Kidney Transplant Recipients: Cross Sectional Prevalence and Diagnostic Accuracy Study of Fecal Immunochemical Testing for Hemoglobin and Colonoscopy. BMJ. 2012 Jul 25;345:e4657.
LaPointe et al. Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing. PLoS One. 2012;7(1):e29059.
Graham et al. Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas. Genes Cancer. 2011 Aug;2(8):829-40.
LaPointe et al. Map of Differential Transcript Expression in the Normal Human Large Intestine. Physiol Genomics. 2008 Mar 14;33(1):50-64.
Smith et al. Comparison of a Brush-Sampling Fecal Immunochemical Test for Hemoglobin with a Sensitive Guaiac-Based Fecal Occult Blood Test in Detection of Colorectal Neoplasia. Cancer. 2006 Nov 1;107(9):2152-9.
Young et al. Prescreening Evaluation of a Brush-Based Fecal Immunochemical Test for Hemoglobin. J Med Screen. 2003;10(3):123-8.
Cole et al. A Randomised Trial of the Impact of New Fecal Hemoglobin Test Technologies on Population Participation in Screening for Colorectal Cancer. J Med Screen. 2003;10(3):117-22.